$3.74
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?
C4 Therapeutics, Inc. (CCCC) Is Up 2.65% in One Week: What You Should Know
C4 Therapeutics (CCCC) Gains Over the Past Month, Can It Go Higher?
Overview
52-week range
$1.36
$4.60
74% of range
Avg surprise (last 3)
+10.1%
Avg reaction (last 2)
+3.2%
50% positive
Latest IV / EM
88%
EM ±20.1% · $4 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.20 | $-0.21 | +4.8% | +46.0% | 0.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.44 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.37 | $-0.38 | +2.6% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-0.37 | $-0.48 | +22.9% | — | +6.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.35 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.26 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.41 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.55 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.73 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$0.23 | -$0.37 | +37.8% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | — | $11M | $6M | $7M | — | $15M | $12M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-28M | — | $-34M | $-29M | $-29M | — | $-28M | $-21M |
| Net income | $-25M | — | $-32M | $-26M | $-26M | — | $-25M | $-18M |
| EPS (diluted) | $-0.20 | — | $-0.44 | $-0.37 | $-0.37 | — | $-0.35 | $-0.26 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $61M | $75M | $59M | $78M | $51M | $55M | $60M | $73M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $245M | $258M | $207M | $225M | $233M | $258M | $273M | $276M |
| Total assets | $329M | $359M | $265M | $297M | $320M | $350M | $376M | $381M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $95M | $102M | $111M | $122M | $124M | $134M | $133M | $134M |
| Total equity | $234M | $257M | $154M | $174M | $195M | $216M | $243M | $247M |